RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      국소 신경학적 장애가 동반되지 않은 급성 뇌중풍 환자에서S-100B 단백의 유용성 = S-100B Protein as a Useful SerologicMarker of Acute Stroke with NonspecificNeurologic Symptoms

      한글로보기

      https://www.riss.kr/link?id=A104608713

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Purpose: There is a distinct probability of severe complications
      with stroke unless patients are administered proper
      treatment at the optimal time. S-100B protein has been
      reported to be elevated in brain injuries. The current study
      investigates the efficacy of serum S-100B protein administration
      during the diagnostic process for patients who have
      had an acute stroke.
      Methods: We prospectively recruited the patients with nonspecific
      neurological symptoms. Non-specific neurological
      symptoms were defined as no focal neurological deficits or
      stroke suspected symptoms with NIHSS score zero. We
      grouped the patients according to the presence of a brain
      lesion (positive vs negative group) by computed tomography
      or magnetic resonance imaging. Using serum S-100B
      protein together with CT/MRI imaging at the time of diagnosis,
      the cutoff value, sensitivities, and specificities were calculated
      in making a diagnosis of acute stroke.
      Results: Thirty one patients were enrolled. The level of
      serum S-100B protein was higher in positive group (median
      0.201, interquartile range 0.134-0.469) than in negative
      group (0.085, 0.060-0.106, p=0.001). In diagnosing acute
      stroke, the sensitivity was 90.9% at a cutoff value for serum
      S-100B protein of 0.10 μg/L . At the cutoff level of serum S-
      100B protein and the specificity was 75.0%.
      Conclusion: The current results suggest that serum S-
      100B protein may be a useful serologic marker for detecting
      acute stroke that is suspected with non-specific neurological
      abnormalities. Further studies are necessary to use the
      marker as a screening method for acute strokes.
      번역하기

      Purpose: There is a distinct probability of severe complications with stroke unless patients are administered proper treatment at the optimal time. S-100B protein has been reported to be elevated in brain injuries. The current study investigates the e...

      Purpose: There is a distinct probability of severe complications
      with stroke unless patients are administered proper
      treatment at the optimal time. S-100B protein has been
      reported to be elevated in brain injuries. The current study
      investigates the efficacy of serum S-100B protein administration
      during the diagnostic process for patients who have
      had an acute stroke.
      Methods: We prospectively recruited the patients with nonspecific
      neurological symptoms. Non-specific neurological
      symptoms were defined as no focal neurological deficits or
      stroke suspected symptoms with NIHSS score zero. We
      grouped the patients according to the presence of a brain
      lesion (positive vs negative group) by computed tomography
      or magnetic resonance imaging. Using serum S-100B
      protein together with CT/MRI imaging at the time of diagnosis,
      the cutoff value, sensitivities, and specificities were calculated
      in making a diagnosis of acute stroke.
      Results: Thirty one patients were enrolled. The level of
      serum S-100B protein was higher in positive group (median
      0.201, interquartile range 0.134-0.469) than in negative
      group (0.085, 0.060-0.106, p=0.001). In diagnosing acute
      stroke, the sensitivity was 90.9% at a cutoff value for serum
      S-100B protein of 0.10 μg/L . At the cutoff level of serum S-
      100B protein and the specificity was 75.0%.
      Conclusion: The current results suggest that serum S-
      100B protein may be a useful serologic marker for detecting
      acute stroke that is suspected with non-specific neurological
      abnormalities. Further studies are necessary to use the
      marker as a screening method for acute strokes.

      더보기

      참고문헌 (Reference)

      1 김찬웅, "경도의 두부 외상 환자에서 S-100B 단백질의 진단적 유용성" 대한응급의학회 17 (17): 574-580, 2006

      2 Kumar S, "Why identification of stroke syndromes is still important" 20 : 78-82, 2007

      3 Schwartz NE, "Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus" 64 : 897-898, 2007

      4 Kato M, "Thrombosed unruptured cerebral aneurysm causing brain infarction followed by subarachnoid hemorrhage--case report" 45 : 472-475, 2005

      5 Masago A, "Thalamic infarction in young adult caused by embolism from an unruptured aneurysm of the posterior cerebral artery--a case report" 45 : 473-476, 1993

      6 Masuda J, "Silent stroke: pathogenesis,genetic factors and clinical implications as a risk factor" 14 : 77-82, 2001

      7 Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline" 348 : 1215-1222, 2003

      8 Wunderlich MT, "Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke" 227 : 49-53, 2004

      9 Stroick M, "Protein S-100B--a prognostic marker for cerebral damage" 13 : 3053-3060, 2006

      10 Cure J, "Prolonged status migrainosus complicated by cerebellar infarction" 47 : 1091-1092, 2007

      1 김찬웅, "경도의 두부 외상 환자에서 S-100B 단백질의 진단적 유용성" 대한응급의학회 17 (17): 574-580, 2006

      2 Kumar S, "Why identification of stroke syndromes is still important" 20 : 78-82, 2007

      3 Schwartz NE, "Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus" 64 : 897-898, 2007

      4 Kato M, "Thrombosed unruptured cerebral aneurysm causing brain infarction followed by subarachnoid hemorrhage--case report" 45 : 472-475, 2005

      5 Masago A, "Thalamic infarction in young adult caused by embolism from an unruptured aneurysm of the posterior cerebral artery--a case report" 45 : 473-476, 1993

      6 Masuda J, "Silent stroke: pathogenesis,genetic factors and clinical implications as a risk factor" 14 : 77-82, 2001

      7 Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline" 348 : 1215-1222, 2003

      8 Wunderlich MT, "Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke" 227 : 49-53, 2004

      9 Stroick M, "Protein S-100B--a prognostic marker for cerebral damage" 13 : 3053-3060, 2006

      10 Cure J, "Prolonged status migrainosus complicated by cerebellar infarction" 47 : 1091-1092, 2007

      11 Savitz SI, "Pitfalls in the diagnosis of cerebellar infarction" 14 : 63-68, 2007

      12 Zaidat OO, "Partially thrombosed aneurysm and stroke" 63 : 1285-, 2004

      13 Alber B, "Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma" 43 : 557-563, 2005

      14 Nor AM, "Misdiagnosis of stroke" 7 : 989-1001, 2007

      15 Vos PE, "Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity" 13 : 632-638, 2006

      16 Kidwell CS, "Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS)" 31 : 71-76, 2000

      17 Zimmermann-Ivol CG, "Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study" 3 : 66-72, 2004

      18 Oppenheim C, "False-negative diffusion-weighted MR findings in acute ischemic stroke" 21 : 1434-1440, 2000

      19 Foerch C, "Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction" 62 : 1130-1134, 2005

      20 Liappas I, "Effect of alcohol detoxification on serum S-100B levels of alcohol-dependent individuals" 20 : 675-680, 2006

      21 Reynolds MA, "Early biomarkers of stroke" 49 : 1733-1739, 2003

      22 Kothari RU, "Cincinnati Prehospital Stroke Scale: reproducibility and validity" 33 : 373-378, 1999

      23 Dieterich M, "Central vestibular disorders" 254 : 559-568, 2007

      24 Rosemergy I, "Brainstem lesions presenting with nausea and vomiting" 120 : U2532-, 2007

      25 "2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" 112 : 111-120, 2005

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2020-05-08 학회명변경 영문명 : The Korean Society Of Emergency Medicine -> The Korean Society of Emergency Medicine KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.22 0.22 0.339 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼